Delivery Order SPE2D018D0006-SPE2D324F3860

Award Date 1/2/24
Potential Completion Date 1/5/24
Potential Value $20K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer located in Westwood, New Jersey. The contract, valued at $5,080.62, is a firm fixed-price delivery order for the supply of 250mg Ryanodex vials, a critical medication used for treating and preventing malignant hyperthermia in high-risk patients. This contract is not associated with any set-aside designations, indicating that...
This federal contract award, with a total ceiling value of $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is a delivery order (SPE2D325F5036) for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price arrangement with a period of performance ending on January 31,...
The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
This is a federal contract award to Eagle Pharmaceuticals, Inc., a specialized pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia in high-risk patients. The contract award, with a ceiling value of $10,161.24, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 29, 2024. This award is not...
Defense Logistics Agency Troop Support Medical awarded a $5,716.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg vials of Ryanodex. The place of performance will be Conshohocken, Pennsylvania and the period of performance extends through November 1, 2023. No set-aside provisions were applied to this contract action. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this delivery order is likely providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,421.76 firm-fixed-price contract is for the supply of RYANODEX 250 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $4,468.92 and a completion date of March 19, 2024. This delivery order is placed under an existing single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of up to $999,999,999.00...
This is a $3,210.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a period of performance through March 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
  • SPE2D018D0006
    Indefinite Delivery Contract
  • SPE2D018D0006-SPE2D324F3860
    Delivery Order

The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Eagle Pharmaceuticals, Inc. to provide the drug Ryanodex (250mg vials). The contract has a completion date of January 5, 2024 and a potential value of $20,322.48. This delivery order is part of Eagle Pharmaceuticals' Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a potential value of $30,890,560 over five years and provides for the supply of drugs, pharmaceuticals, and hematology-related products to VA medical facilities across New Jersey, Pennsylvania, and Delaware. The contract does not include any set-aside designation or major subcontractors.

Generated 5/17/24, 9:27 AM